|
Atypical Neuroleptics
Citations 51-60 of 335 total displayed.
|
Past content
(since Jun 2002):
|
- Articles
Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison
- Joseph P. McEvoy, Jeffrey A. Lieberman, Diana O. Perkins, Robert M. Hamer, Hongbin Gu, Arthur Lazarus, Dennis Sweitzer, Christina Olexy, Peter Weiden, and Stephen D. Strakowski
Am J Psychiatry 2007; 164: 1050-1060.
[Abstract]
[Full text]
[PDF]
- Articles
Effects of Olanzapine, Quetiapine, and Risperidone on Neurocognitive Function in Early Psychosis: A Randomized, Double-Blind 52-Week Comparison
- Richard S.E. Keefe, John A. Sweeney, Hongbin Gu, Robert M. Hamer, Diana O. Perkins, Joseph P. McEvoy, and Jeffrey A. Lieberman
Am J Psychiatry 2007; 164: 1061-1071.
[Abstract]
[Full text]
[PDF]
- Treatment in Psychiatry
Neuroleptic Malignant Syndrome
- Jeffrey R. Strawn, Paul E. Keck, Jr., and Stanley N. Caroff
Am J Psychiatry 2007; 164: 870-876.
[Full text]
[PDF]
- Articles
Adverse Subjective Experience With Antipsychotics and Its Relationship to Striatal and Extrastriatal D2 Receptors: a PET Study in Schizophrenia
- Romina Mizrahi, Pablo Rusjan, Ofer Agid, Ariel Graff, David C. Mamo, Robert B. Zipursky, and Shitij Kapur
Am J Psychiatry 2007; 164: 630-637.
[Abstract]
[Full text]
[PDF]
- Editorials
Lessons From Each Drug Trial
- Stephen R. Marder
Am J Psychiatry 2007; 164: 375-376.
[Full text]
[PDF]
- Editorials
Great(er) Expectations
- John Lauriello
Am J Psychiatry 2007; 164: 377-379.
[Full text]
[PDF]
- Articles
Effectiveness of Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia After Discontinuing Perphenazine: A CATIE Study
- T. Scott Stroup, Jeffrey A. Lieberman, Joseph P. McEvoy, Marvin S. Swartz, Sonia M. Davis, George A. Capuano, Robert A. Rosenheck, Richard S.E. Keefe, Alexander L. Miller, Irving Belz, John K. Hsiao,, for the CATIE Investigators
Am J Psychiatry 2007; 164: 415-427.
[Abstract]
[Full text]
[PDF]
- Articles
Effects of Antipsychotic Medications on Psychosocial Functioning in Patients With Chronic Schizophrenia: Findings From the NIMH CATIE Study
- Marvin S. Swartz, Diana O. Perkins, T. Scott Stroup, Sonia M. Davis, George Capuano, Robert A. Rosenheck, Fred Reimherr, Mark F. McGee, Richard S.E. Keefe, Joseph P. McEvoy, John K. Hsiao, Jeffrey A. Lieberman, for the CATIE Investigators
Am J Psychiatry 2007; 164: 428-436.
[Abstract]
[Full text]
[PDF]
- Letters to the Editor
Confounding by Indication and the Risk of Hyperlipidemia in Observational Studies of Antipsychotics
- FERNANDO RICO-VILLADEMOROS and ELENA P. CALANDRE
Am J Psychiatry 2007; 164: 525-b-526-b.
[Full text]
[PDF]
- Letters to the Editor
Dr. Olfson and Colleagues Reply
- MARK OLFSON, STEVEN C. MARCUS, PATRICIA COREY-LISLE, A.S. TUOMARI, PATRICIA HINES, and GILBERT J. L’ITALIEN
Am J Psychiatry 2007; 164: 526.
[Full text]
[PDF]
|
|
